cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Innoviva Inc
7 own
7 watching
Current Price
$15.26
$0.02
(0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,070.16M
52-Week High
52-Week High
16.86000
52-Week Low
52-Week Low
10.64000
Average Volume
Average Volume
0.96M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
4.7845
iconMarket Capitalization1,070.16M
icon52-Week High16.86000
icon52-Week Low10.64000
iconAverage Volume0.96M
iconDividend Yield--
iconP/E Ratio4.7845
What does the Innoviva Inc do?
Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ...
Read More
How much money does Innoviva Inc make?
News & Events about Innoviva Inc.
Business Wire
10 months ago
Innoviva, Inc. (Nasdaq: INVA) (Innoviva), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that Nasdaq has halted trading of Innovivas common stock. The U.S. Food and Drug Administrations (FDAs) Antimicrobial Drugs Advisory Committee is...
Zolmax
12 months ago
Innoviva (NASDAQ:INVA Get Rating) had its price objective cut by The Goldman Sachs Group from $15.00 to $13.00 in a research report report published on Friday, Benzinga reports. They currently have a neutral rating on the biotechnology companys stock. Several other equities analysts ...
Globe Newswire
1 year ago
Six abstracts selected for presentation, including three oral presentationsWALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned ...
Business Wire
1 year ago
Innoviva, Inc. (Nasdaq: INVA) (Innoviva), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of La Jolla Pharmaceutical...
Ticker Report
1 year ago
Qube Research Technologies Ltd raised its holdings in Innoviva, Inc. (NASDAQ:INVA Get Rating) by 9.3% in the first quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 51,432 shares of the biotechnology companys ...
Frequently Asked Questions
Frequently Asked Questions
What is Innoviva Inc share price today?
plus_minus_icon
Can Indians buy Innoviva Inc shares?
plus_minus_icon
How can I buy Innoviva Inc shares from India?
plus_minus_icon
Can Fractional shares of Innoviva Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Innoviva Inc stocks?
plus_minus_icon
What is today’s traded volume of Innoviva Inc?
plus_minus_icon
What is today’s market capitalisation of Innoviva Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Innoviva Inc?
plus_minus_icon
What percentage is Innoviva Inc down from its 52-Week High?
plus_minus_icon
What percentage is Innoviva Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$15.26
$0.02
(0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00